2023 The Final Countdown, page-73

Imagine if msb deliberately only raises say $20m USD from private holders! That would extend the runway by 2 months on top of current cash balance to slightly past potential approval. Not what ecool is suggesting about an massive placement, which actually gives the shorters an out.
in the past when the SP was stronger, raising more made sense,
this is going only one of 2 ways, approval or non approval.
approval would mean with raising $20m USD or approx 30m shares, then the shorts would have no choice other than to purchase on the market, sp recovers, you then receive milestone receipts/ pediatric voucher or partnership funds because to an external partner this would be proof the FDA is serious about stem cells and will allow this new market segment to operate in a regulated environment unlike autologous cells which they recently lost in the courts against, or you raise funds at the higher sp as it recovers, eventually raising enough revenue to be self sustaining!
alternatively, share price tanks even further, and shorters win.

my bet and future is on the former, but hey it's been proved more than once, msb is the master of raising funds from left field.

not financial advice